Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Login Sign up free
Home Screener Maps Charts News Groups Insider Futures Forex Crypto Portfolio Calendar
Pricing

New Elite Feature:   Find Similar Charts in Seconds

Learn How
Market News Market Pulse Stocks News ETF News Crypto News

Kiniksa Pharmaceuticals International, Plc

Contributing Author

Recent Articles by Kiniksa Pharmaceuticals International, Plc

Sep-04
Kiniksa Pharmaceuticals to Present at Wells Fargo 21st Annual Healthcare Conference KNSA GlobeNewswire
Aug-07
Kiniksa Pharmaceuticals to Present at Canaccord Genuity 46th Annual Growth Conference KNSA GlobeNewswire
Jul-28
Kiniksa Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Portfolio Execution KNSA +25.03% GlobeNewswire
Jul-23
Kiniksa Pharmaceuticals to Report Second Quarter 2026 Financial Results on July 28, 2026 KNSA GlobeNewswire
May-29
Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences KNSA GlobeNewswire
Apr-28
Kiniksa Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Portfolio Execution KNSA +23.48% GlobeNewswire
Apr-23
Kiniksa Pharmaceuticals to Report First Quarter 2026 Financial Results on April 28, 2026 KNSA GlobeNewswire
Apr-08
Kiniksa Pharmaceuticals Launches Targeted Direct-To-Consumer TV Campaign for ARCALYST (rilonacept) in Recurrent Pericarditis KNSA GlobeNewswire
Feb-25
Kiniksa Pharmaceuticals to Present at TD Cowen 46th Annual Health Care Conference KNSA GlobeNewswire
Feb-24
Kiniksa Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Portfolio Execution KNSA -8.21% GlobeNewswire
Feb-19
Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 KNSA GlobeNewswire
Jan-12
Kiniksa Pharmaceuticals Provides Corporate Update KNSA GlobeNewswire
Jan-07
Kiniksa Pharmaceuticals to Present at 44th Annual J.P. Morgan Healthcare Conference KNSA GlobeNewswire
Nov-12
Kiniksa Pharmaceuticals to Present at Jefferies Global Healthcare Conference in London KNSA GlobeNewswire
Oct-28
Kiniksa Pharmaceuticals Reports Third Quarter 2025 Financial Results and Recent Portfolio Execution KNSA GlobeNewswire
Oct-23
Kiniksa Pharmaceuticals to Report Third Quarter 2025 Financial Results on October 28, 2025 KNSA GlobeNewswire
Oct-17
Kiniksa Pharmaceuticals Announces U.S. Orphan Drug Designation for KPL-387 for the Treatment of Pericarditis KNSA GlobeNewswire
Aug-28
Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences KNSA GlobeNewswire
Jul-29
Kiniksa Pharmaceuticals Reports Second Quarter 2025 Financial Results and Recent Portfolio Execution KNSA +12.32% GlobeNewswire
Jul-24
Kiniksa Pharmaceuticals to Report Second Quarter 2025 Financial Results on July 29, 2025 KNSA GlobeNewswire
Affiliate • Advertise • API and Exports • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)